These short chain fatty acids-enriched EVs regulate hepatic lipid metabolism by activating FXR and TGR5 signaling pathways, both of which are critical for maintaining bile acid homeostasis and preventing hepatic steatosis [108]. The gene discussed is NR1H4; the disease is Hepatic steatosis.